Incredible first day at FOCAL+ 2025, amazing opportunity to learn from the leaders in the Focal Therapy field. Thank you, Dr. Arvin K. George, MD and Dr. Abhinav Sidana for their incredible organization, as every year!#Focal2024

How do we make sense of two “negative” trials in NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence? Emil Hodzic-Santor and Michael Fralick share some insights in this editorial: eviden.cc/3OYutgJ

Just published in Urologic Oncology, a Meta-Analysis testing the accuracy of Biparametric #MRI in 5075 patients. This alternative is demostrating to be a feasible option for #ProstateCancer screening. Thank you Centro Urológico UroVallarta Natalia García Jesus Juarez

Is biparametric MRI a feasible option for detecting clinically significant prostate cancer?: A systematic review and meta-analysis buff.ly/4a2Nicm

The groundbreaking HIFI Study published by European Urology found that mid-term salvage treatment-free outcomes are comparable, with a better safety profile favoring HIFU over radical prostatectomy. Focal One provided noninferior cancer control for patients in the study

🚨 FEATURED ON UROTODAY! 🚨 📄Our systematic review & Single-arm meta-analysis on High-Intensity Focused Ultrasound (HIFU) for #BPH, on UroToday.com ! 🔗 Read more: tinyl.io/C8EY #Urology #ProstateHealth #LUTS #HIFU Jesus Juarez UroVallarta Centro Urológico Natalia García

Mexico está hasta la madre de llorar sangre, de mirar como el Estado deshonra la memoria de los nuestros ocultando sus muertes y desapariciones, como escudan al narco callando los horribles crímenes contra nuestros jóvenes. ¡Queremos JUSTICIA! #FueElEstado #LutoNacionalMéxico

🤖 Time for a new PARADIGM? Kasivisvanathan et al. outline how AI could revolutionize #prostatecancer diagnosis on MRI. The PARADIGM trial will provide level 1 evidence on AI's role in detecting clinically significant disease. 🔗 buff.ly/3BZpq1a #AI #UroOncology

📰 Just published in Prostate Cancer and Prostatic Diseases: our latest meta-analysis suggests contrast may not be needed to detect prostate cancer. Bp-MRI vs Mp-MRI — 5,000+ patients. Less risk. Less cost. Same accuracy. Full paper 👉 shorturl.at/Fp8im #UroOncology #ProstateCancer #MRI

Biparametric vs Multiparametric MRI for Prostate Cancer DiagnosisThe PRIME Diagnostic Clinical Trial jamanetwork.com/journals/jama/… Investigators compared biparametric MRI (without contrast) to standard multiparametric MRI for diagnosing clinically significant #ProstateCancer in